We are a non-profit association made up of pharmaceutical companies, specialised in rare diseases, that are committed to discovering, researching, developing and commercialising innovative therapies that improve the lives of patients and their families.
RESEARCH AND COMMITMENT to rare diseases
Do you want to be part of AELMHU?
AELMHU prepares, on a quarterly and annual basis,
reports on access to orphan drugs in Spain.
Orphan Drug Annual Access Report 2022
AELMHU publishes, once again this year, the annual data on access to orphan drugs in Spain in order to monitor the evolution of access to this type of treatment in our country. This ... Read more